Creating biodegradable vascular grafts for better artery health
Biodegradable Elastomers and Resorbable Synthetic Vascular Grafts
This study is working on creating new, safe materials for blood vessel replacements that can dissolve in your body after they’ve helped, especially for kids, so they can grow without complications.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michigan Technological University NIH-funded |
| Lab location | 1 site (Houghton, United States) |
| Project ID | NIH-10580321 on NIH RePORTER |
What this research studies
This research focuses on developing new biodegradable elastomers to create synthetic vascular grafts that can safely dissolve in the body after serving their purpose. The approach aims to address the limitations of current grafts, which often fail in small arteries due to complications like thrombosis. By engineering grafts that can grow with the patient, particularly benefiting pediatric patients, the research seeks to enhance the body's natural healing processes. The project involves designing and synthesizing new materials that are biocompatible and can be tailored for optimal performance in vascular applications.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients requiring vascular grafts, especially those who cannot use autografts due to limited availability.
Not a fit: Patients with conditions that do not require vascular grafting or those who are not candidates for surgery may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with safer and more effective options for vascular grafts, reducing complications and improving recovery outcomes.
How similar studies have performed: While there have been attempts to create biodegradable grafts, this specific approach using novel polyester elastomers is relatively new and has not yet been widely tested.
Where this research is happening
Houghton, United States
- Michigan Technological University — Houghton, United States (Active)
Researchers
- Principal investigator: Ding, Xiaochu — Michigan Technological University
- Study coordinator: Ding, Xiaochu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.